HYBRID EVENT: You can participate in person at London, UK or Virtually from your home or work.

6th Edition of Cardiology World Conference

September 15-17, 2025 | London, UK

September 15 -17, 2025 | London, UK

Cardio 2025

Yong Xiao Wang, Speaker at Heart Conferences
Keynote Presentation (In-Person)
Yong Xiao Wang, Albany Medical Center, United States

As a common and devastating lung disease, pulmonary hypertension (PH) has a significant rate of both morbidity and death mortality. The current primary interventions for this disease are to use non-specific vasodilators, but patients do not always respond well to these non-specif [....] » Read More

Arthur J Siegel, Speaker at Cardiovascular Conference
Keynote Presentation (In-Person)
Arthur J Siegel, Massachusetts General Hospital, United States

While habitual endurance exercise such as training for a marathon is quintessentially cardioprotective, running such a race paradoxically confers a transiently increased risk for cardiac arrest and sudden death. The frequency of such events increased significantly in United State [....] » Read More

Abraham Teddy Weiss, Speaker at Cardiology Conferences
Keynote Presentation (In-Person)
Abraham Teddy Weiss, Hadassah University Hospital, Israel

Sudden cardiac death (SCD)-caused by ventricular fibrillation (VF) or standstill-is one of the biggest unmet need in public health: it is unpredictable and occurs in about 1000 persons/day in US and Europe alone with very poor survival. Since survival drops by 10% for every minut [....] » Read More

Sekib Sokolovic, Speaker at Cardiology Conferences
Keynote Presentation (In-Person)
Sekib Sokolovic, Sarajevo University Clinical Center, Bosnia and Herzegowina

Introduction: The low grade chronic inflammation (LCGI)  is response to the underlying disorders, injuries, antigen and is result of the failure to acute infection, viruses, tuberculosis, protozoa, fungal and foreign material. The risk factor of LCGI are smoking, obesity, hi [....] » Read More

Thomas Bernd Dschietzig, Speaker at Cardiovascular Conference
Keynote Presentation (In-Person)
Thomas Bernd Dschietzig, Relaxera GmbH & Co. KG, Germany

Human relaxin-2 (hRlx-2) is a hormone of pregnancy that has engendered a great deal of interest as a therapy for various cardiovascular and inflammatory diseases, among them Acute Heart Failure and Systemic Scleroderma. Here, we propose and summarize data showing that Rlx-2 repre [....] » Read More

Iris Panagiota Efthymiou, Speaker at Heart Conferences
Keynote Presentation (In-Person)
Iris Panagiota Efthymiou, University of Greenwich, United Kingdom

Effective communication is critical in cardiology, where the stakes often involve life-altering decisions. This presentation explores the intersection of empathy and precision in communication, emphasizing the cardiologist’s role in fostering trust, understanding, and patie [....] » Read More

Y J H J Taverne, Speaker at Cardiovascular Conference
Keynote Presentation (In-Person)
Y J H J Taverne, Erasmus University Medical Center, Netherlands

Cardiac transplantation remains the golden standard for patients with end-stage heart failure when therapeutic approaches and interventions fail to reverse HF progression. Traditionally, hearts are transplanted from brain-death (DBD) donors where the heart is beating at time of p [....] » Read More

Sergey Suchkov, Speaker at Cardiology Conferences
Keynote Presentation (In-Person)
Sergey Suchkov, R&D Director of the National Center for Human Photosynthesis, Mexico

A new systems approach to diseased states and wellness result in a new branch in the healthcare services, namely, Personalized and Precision Medicine (PPM). To achieve the implementation of PPM concept, it is necessary to create a fundamentally new strategy based upon the recogni [....] » Read More

Trevor Tucker, Speaker at Heart Conferences
Oral Presentation (In-Person)
Trevor Tucker, T Tucker Inc, Canada

The stiffening of arteries has been widely recognized as a major contributor to cardiovascular diseases and all cause mortality. Arterial stiffening has significant association with arteriosclerosis and atherosclerosis development. In spite of the world-wide recognition, arterial [....] » Read More

Maria Del Pino, Speaker at Heart Conferences
Oral Presentation (In-Person)
Maria Del Pino, Houston Methodist Hospital, United States

Background: Atrial fibrillation (AF) is a common cardiac arrhythmia associated with significant cardiovascular morbidity and mortality, as well as cognitive impairment (CI). The interplay between AF and CI is complex, involving various pathophysiological changes and numerous risk [....] » Read More

Vaibhav Sharma, Speaker at Cardiology Conferences
Oral Presentation (In-Person)
Vaibhav Sharma, St. Louis Heart and Vascular, United States

Background: Endocardial calcification is a rare cardiac condition with limited documented cases, particularly in non-tropical regions. This case report explores an unusual presentation of incidental endomyocardial calcification in a patient without typical predisposing systemic d [....] » Read More

Vaibhav Sharma, Speaker at Cardiology Conferences
Oral Presentation (In-Person)
Vaibhav Sharma, St. Louis Heart and Vascular, United States

Background: The cardiovascular implications of marijuana use have gained increasing attention in recent medical literature. While chronic cannabis consumption has been linked to various cardiovascular events, comprehensive documentation of acute myocardial infarction in young adu [....] » Read More

Y J H J Taverne, Speaker at Cardiovascular Conference
Oral Presentation (In-Person)
Y J H J Taverne, Erasmus University Medical Center, Netherlands

Full midline sternotomy remains the most common incision to correct congenital cardiac defects. Although many minimal invasive programs exist for the adult population worldwide, only a few centers have adopted such a program for the pediatric population. The rise of novel interve [....] » Read More

Ziyu Zhou, Speaker at Cardiology Conferences
Oral Presentation (In-Person)
Ziyu Zhou, Erasmus University Medical Center, Netherlands

Congenital heart disease (CHD) continues to pose significant challenges in paediatric cardiology, and Tetralogy of Fallot (ToF) stands out as a condition in need of improved translational models. Traditional in vitro and animal-based systems provide valuable insights but often fa [....] » Read More

Aleksandr Filippov, Speaker at Cardiology Conferences
Oral Presentation (In-Person)
Aleksandr Filippov, St. Petersburg State University, Russian Federation

Background: Smoking status (SS) is associated with structural and functional vascular changes which may lead to increased arterial stiffness and, as a consequence, the formation of early vascular aging. The purpose of this study was to investigate the relationship betwe [....] » Read More

Sergey Suchkov, Speaker at Cardiology Conferences
Oral Presentation (In-Person)
Sergey Suchkov, R&D Director of the National Center for Human Photosynthesis, Mexico

The approaches securing cardiac regeneration in post-infarction period are not available to be practiced. The key problem is the identity of cells be born to generate functionally active cardiac myocytes replenishing those being lost during ischemia. With identification of reside [....] » Read More

Sara Ismail Abdelhalim Ismail, Speaker at Cardiology Conferences
Oral Presentation (In-Person)
Sara Ismail Abdelhalim Ismail, Al-Sabah Hospital-Medical, Kuwait

Introduction: Left ventricular (LV) thrombus accounts for up to 10% of cardioembolic strokes. It is frequently observed in patients with a history of myocardial infarction, particularly those with anterior STEMI, reduced left ventricular ejection fraction (LVEF), non-ischemic car [....] » Read More

Ikram Khan, Speaker at Heart Conferences
Oral Presentation (In-Person)
Ikram Khan, Lanzhou University, China

Our study investigates the interplay between the microbiome and metabolome in acute myocardial infarction (AMI), focusing on the diagnostic potential of blood, gut, and oral microbiota and their metabolomic signatures. Blood, fecal, and saliva samples from AMI patients and health [....] » Read More

Kanchan Kanchan, Speaker at Heart Conferences
Oral Presentation (In-Person)
Kanchan Kanchan, Birmingham Heartlands Hospital, United Kingdom

We present the case of a 40-year-old male who experienced a seizure-like episode, later diagnosed as torsade's de pointes (TDP), highlighting the diagnostic and management challenges of this atypical presentation. The episode characterized by generalized shaking without tongu [....] » Read More

Yankey Yundung, Speaker at Cardiovascular Conference
Oral Presentation (In-Person)
Yankey Yundung, University Hospital Zurich, Switzerland

The baroreflex is a key mechanism for regulating blood pressure and heartbeat, mediated by mechanosensitive baroreceptors. The entire knowledge on baroreceptors, however, has been derived predominantly from animal studies. No data focusing on the molecular nature of the human aor [....] » Read More

Chun Wu, Speaker at Cardiology Conferences
Oral Presentation (In-Person)
Chun Wu, Huazhong University of Science and Technology, China

Purpose: Decreased diastolic(DD) function may be one of the early manifestations of acute rejection after heart transplantation. Left atrioventricular coupling index (LACl) is associated with DD severity. The purpose of this study was to investigate the novel prognostic value of [....] » Read More

Yanmin Xu, Speaker at Cardiology Conferences
Oral Presentation (In-Person)
Yanmin Xu, Tianjin Medical University Second Hospital, China

Objective: The platelet-to-lymphocyte ratio (PLR) and white blood cell to lymphocyte ratio (WLR) are potential markers of inflammation. This study aimed to investigate the relationship between PLR, WLR, and the risk of major adverse cardiovascular events (MACE) in patients w [....] » Read More

Zoya Khan, Speaker at Cardiology Conferences
Poster Presentation (In-Person)
Zoya Khan, Lakeland Regional Health, United States

Introduction: Anomalous origin of the right coronary artery (RCA) is a rare congenital condition, accounting for less than 1% of coronary anomalies. While many patients are asymptomatic, the anomalous course can lead to myocardial ischemia through external compression rather than [....] » Read More

Michael Sabina, Speaker at Cardiology Conferences
Poster Presentation (In-Person)
Michael Sabina, Lakeland Regional Health Medical Center, United States

This presentation will focus on the critical and complex decision-making process involved in managing ventricular septal defects (VSDs) that develop after myocardial infarction (MI). Although VSDs following MI are rare, they represent a life-threatening complication with a high m [....] » Read More

Malik Takreem Ahmad, Speaker at Heart Conferences
Poster Presentation (In-Person)
Malik Takreem Ahmad, King’s College London, United Kingdom

Background: Rheumatic heart disease (RHD) is a leading cause of valvular heart disease globally, particularly in low- and middle-income countries, where it significantly contributes to non-obstetric maternal morbidity and mortality. Echocardiography has emerged as a promising too [....] » Read More

Ali Elshamy, Speaker at Heart Conferences
Poster Presentation (In-Person)
Ali Elshamy, Northampton General Hospital, United Kingdom

Introduction: Pulmonary hypertension is a chronic progressive disease characterized by raised pulmonary vascular resistance ultimately leading to right sided heart failure. Amongst the current available options for treatment, Epoprostenol has been widely proven to improve sy [....] » Read More

Raghul Ganesapandi, Speaker at Cardiology Conferences
Poster Presentation (In-Person)
Raghul Ganesapandi, Director Cath Lab J. P Heart Institute, India

Background: Age is a key factor influencing outcomes for patients with acute coronary syndromes (ACS). However, in community practice, there is a noticeably lower utilization of cardiovascular medications and invasive treatments among elderly patients with ACS, even though t [....] » Read More

Nabihah Hussaini, Speaker at Cardiology Conferences
Poster Presentation (In-Person)
Nabihah Hussaini, University Hospital Lewisham, United Kingdom

Presentation: A 54-year-old woman was referred with an 8-week history of pressure sensations over the chest and epigastrium unrelated to exertion. She presented to the Emergency Department 4 weeks prior but self-discharged against medical advice due to the long wait time. Diag [....] » Read More

Farrukh Malik, Speaker at Cardiovascular Conference
Poster Presentation (In-Person)
Farrukh Malik, National institute of cardiovascular diseases, Pakistan

Introduction: Chronic limb ischemia (CLI), the terminal manifestation of peripheral artery disease, has an estimated prevalence of 6.5 million in the United States and Japan, with an annual incidence of 2.3% per year. Patients diagnosed with CLI have a 1-year mortality rate of ap [....] » Read More

Farrukh Malik, Speaker at Cardiovascular Conference
Poster Presentation (In-Person)
Farrukh Malik, National institute of cardiovascular diseases, Pakistan

Introduction: Coronary artery disease (CAD) is primarily influenced by modifiable risk factors including smoking. Smoking Cannabis is one of the most widely used illicit substances worldwide, which is on the rise due to legalization in different parts of the world, and it ha [....] » Read More

Robert J Chilton, Speaker at Cardiology Conferences
Keynote Presentation (Virtual)
Robert J Chilton, University of Texas Health Science Center San Antonio, United States

Finerenone is a non-steroidal mineralocorticoid receptor antagonist (MRA) designed to manage heart failure, especially in patients with chronic kidney disease (CKD) and type 2 diabetes. Heart failure and CKD frequently co-exist, and the combination poses a particularly high cardi [....] » Read More

Mekhman N Mamedov, Speaker at Cardiology Conferences
Keynote Presentation (Virtual)
Mekhman N Mamedov, National Research Center for Preventive Medicine, Russian Federation

Atherosclerosis has a long preclinical phase and the risk of cardiovascular events may be high in patients in the asymptomatic stage of the disease (subclinical atherosclerosis, SA). The presence of classical risk factors increases the likelihood of developing cardiovascular even [....] » Read More

Syed Raza, Speaker at Cardiovascular Conference
Keynote Presentation (Virtual)
Syed Raza, Awali Hospital, Bahrain

Cardiovascular disease (CVD) is the leading cause of death and disability worldwide. The primary prevention of CVD is dependent upon the ability to identify high-risk individuals long before the development of overt events. This highlights the need for accurate risk stratificatio [....] » Read More

Omar Sami Abdelhai, Speaker at Cardiology Conferences
Oral Presentation (Virtual)
Omar Sami Abdelhai, Henry Ford Health, United States

Background: Left ventricular systolic function is not well-characterized in patients with low high-sensitivity cardiac troponin I (hs-cTnI) evaluated in the Emergency Department (ED). Methods: A stepped-wedge randomized trial conducted from July 2020 to March 2021, involved pa [....] » Read More

Randa Elzein, Speaker at Cardiovascular Conference
Oral Presentation (Virtual)
Randa Elzein, SUNY Upstate Medical University, United States

Introduction: Atrial Fibrillation (AF) is the most common sustained arrhythmia, and its incidence and prevalence are growing in the United States and worldwide. Catheter ablation was successful in decreasing recurrence of AF by 48% and symptomatic AF by 51% compared with drug the [....] » Read More

Maria Borrell, Speaker at Cardiology Conferences
Oral Presentation (Virtual)
Maria Borrell, Institut de Recerca Sant Pau - Centre CERCA, Spain

Atherosclerosis, the leading cause of cardiovascular diseases, is driven by high blood cholesterol levels and chronic inflammation. The disruption of the hepatic interaction between Proprotein Convertase Subtilisin/Kexin 9 (PCSK9) and Low-Density Lipoprotein Receptor (LDLR) downr [....] » Read More

Agustin Joison, Speaker at Cardiology Conferences
Oral Presentation (Virtual)
Agustin Joison, Cordoba Catholic University, Argentina

Introduccion: Diabetes is a major comorbidity for heart failure and is more common than myocardial infarction with an increased risk of more than 50% in cardiovascular disease. Recently, high-sensitivity cardiac troponin T (hs-cTnT)  has been shown to be associated with the [....] » Read More

Yasser Mohammed Hassanain Elsayed, Speaker at Cardiovascular Conference
Oral Presentation (Virtual)
Yasser Mohammed Hassanain Elsayed, Egyptian Ministry of Health, Egypt

Aim of the study: The study is aimed to clear the cycle effect of fear or anxiety and calm or reassurance on electrocardiographic ST-segment depression in patients present with angina with possible coronary artery spasms. Background: Anxiety and fear have undoubted hazardous e [....] » Read More

Fatima Sajid, Speaker at Cardiology Conferences
Oral Presentation (Virtual)
Fatima Sajid, King Edward Medical University, Pakistan

This retrospective cohort study aimed to compare the one-year outcomes of anterior-posterior (AP) and anterior-lateral (AL) methods of cardioversion for atrial fibrillation (AF). A total of 2168 patients were included, with 1125 patients in the AP cardioversion group (Group 1) an [....] » Read More

Imran Ahmad Khan, Speaker at Heart Conferences
Oral Presentation (Virtual)
Imran Ahmad Khan, MNS University of Agriculture, Pakistan

Purpose: Transgenders are the most neglected population in South Asia especially in Pakistan. Before 2018 they do not have any rights and privileges. The first study was planned to investigate the effects of high-intensity circuit training on cardiometabolic and cardiorespiratory [....] » Read More

Kanran Wang, Speaker at Heart Conferences
Oral Presentation (Virtual)
Kanran Wang, Chongqing University Cancer Hospital, China

Background: This study aimed to examine the longitudinal association between the triglyceride glucose-body mass index (TyG-BMI) index and memory-related diseases (MDs) among Chinese adults. Methods: Data were obtained from the China Health and Retirement Longitudinal Study (CH [....] » Read More

Rajaram, Speaker at Cardiology Conferences
Oral Presentation (Virtual)
Rajaram, Meenakshi Mission Hospital and Research Centre, India

Cardiac rhabdomyoma is a hamartoma comprised of cardiac myocytes. It is most commonly diagnosed in infancy, 70 to 90% of whom have TSC (Tuberous sclerosis complex). It usually shows spontaneous regression within the first two years of life and hence is extremely rare in adults. I [....] » Read More

Joshua Shiako, Speaker at Cardiovascular Conference
Oral Presentation (Virtual)
Joshua Shiako, Komfo Anokye Teaching Hospital, Ghana

Background: Cardiovascular disease risk assessment tools are algorithms used to predict an individual’s chance of developing a cardiovascular disease within a specific period. It has been shown that awareness of one’s risk of developing a particular disease often resu [....] » Read More

Mersal Samimi, Speaker at Cardiology Conferences
Poster Presentation (Virtual)
Mersal Samimi, University of California, United States

Background: While hyperthyroidism and atrial fibrillation has been extensively studied, in patients with atrial fibrillation, much remains unexplored regarding the presence of concurrent subclinical hypothyroidism and in-hospital outcomes. We will explore the national inpatient s [....] » Read More

Mersal Samimi, Speaker at Cardiology Conferences
Poster Presentation (Virtual)
Mersal Samimi, University of California, United States

Introduction: Constrictive pericarditis is a rare disease where calcification of the pericardium leads to restricted diastolic filling of the heart. Due to its non-specific symptoms, such as dyspnea with exertion, peripheral edema, and chest discomfort, it can mimic many primary [....] » Read More

Jas Virk, Speaker at Cardiovascular Conference
Poster Presentation (Virtual)
Jas Virk, Mountain Area Health Education Center, United States

Introduction: Mucous membrane pemphigoid (MMP) is a rare, chronic, autoimmune disease presenting with subepithelial blistering and erosive lesions on the mucosal surface of the mouth, eyes, and occasionally the pharynx. While initial treatment of mild pemphigoid of the oral cavit [....] » Read More

Andrea Martinez, Speaker at Cardiology Conferences
Poster Presentation (Virtual)
Andrea Martinez, Massachusetts General Hospital, United States

Background: Aortic stenosis (AS) is a progressive condition with high morbidity and mortality if left untreated. Currently, there are clinical guidelines to help provide physicians with recommendations for clinical decisions. Class 2 guidelines have inherently weaker evidenc [....] » Read More

Manik Dayal, Speaker at Cardiovascular Conference
Poster Presentation (Virtual)
Manik Dayal, Rutgers University New Jersey Medical School, United States

Background: Heart failure education is crucial for improving patient outcomes, yet barriers persist due to varying levels of health literacy. Patients with lower literacy often struggle with understanding complex medical concepts, impairing medication adherence and disease m [....] » Read More

Ayushi Mohan, Speaker at Heart Conferences
Poster Presentation (Virtual)
Ayushi Mohan, New York Medical College at St. Michael's Medical Center, United States

Introduction: Current treatment recommendations for secondary mitral regurgitation (MR) include transcatheter edge-to-edge repair (TEER) and mitral valve surgery. Surgical repair (SR) has been the traditional approach but TEER has emerged as a less invasive alternative. Currently [....] » Read More

Ayushi Mohan, Speaker at Heart Conferences
Poster Presentation (Virtual)
Ayushi Mohan, New York Medical College at St. Michael's Medical Center, United States

Introduction: Tricuspid regurgitation (TR) is a common valvular disease linked to significant morbidity and mortality. It has a well-documented independent prognostic impact. Surgical repair (SR) is a recognized option for severe or progressive TR, or as an adjunct to mitral valv [....] » Read More

Mohammad Ali Darbandi, Speaker at Heart Conferences
Poster Presentation (Virtual)
Mohammad Ali Darbandi, Nafas Pharmed Pharmaceutical Company, Iran (Islamic Republic of)

Spironolactone belongs to the second class of the bio pharmacy classification system (BCS). All of the drugs, which are classified in this group, suffer from the solubility as the major problem. For this reason, application of any different technique which increases the solubilit [....] » Read More

Will be updated soon......
Watsapp